Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMBRACE: Clesrovimab in Infants During First RSV Season
NCT07824167Phase 4Not yet recruiting
- Sponsor
- Emory University
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
A Phase 4 trial of clesrovimab-cfor in respiratory syncytial virus infection (RSV), sponsored by Emory University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
clesrovimab-cfor
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT07824167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824167.